Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13905560 | 0.83 | ACE (0.42) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL12354387 | 0.81 | KDM4E (0.61) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL22651865 | 0.81 | ACE (0.50) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL27447128 | 0.81 | KDM4E (0.61) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL27447129 | 0.81 | ACE (0.50) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL26758194 | 0.79 | ACE (0.44) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL24239485 | 0.78 | ACE (0.43) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL17524631 | 0.77 | KDM4E (0.45) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL1058214 | 0.77 | KDM4E (0.56) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL19729234 | 0.77 | KDM4E (0.45) | ACEKDM4EMAPTTHRBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100249027-A1 | CRF CONJUGATES WITH EXTENDED HALF-LIVES | HENRY WILLIAM | 2010-09-30 | — | — | US | disclosed |
| US-20100249027-A1 | CRF CONJUGATES WITH EXTENDED HALF-LIVES | HENRY WILLIAM | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249027-A1 | CRF CONJUGATES WITH EXTENDED HALF-LIVES | CRH, CRHR2, CRHR1 | ACE 571/4885KDM4E 3475/4885MAPT 2882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.